[Mechanisms by which the bone marrow microenvironment of myelodysplastic neoplasms contributes to disease progression].
作者信息
Hong M H, Chang C K
机构信息
Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Apr 14;44(4):350-352. doi: 10.3760/cma.j.issn.0253-2727.2023.04.018.
Abstract
摘要
相似文献
1
[Mechanisms by which the bone marrow microenvironment of myelodysplastic neoplasms contributes to disease progression].骨髓增生异常肿瘤的骨髓微环境促成疾病进展的机制
Zhonghua Xue Ye Xue Za Zhi. 2023 Apr 14;44(4):350-352. doi: 10.3760/cma.j.issn.0253-2727.2023.04.018.
2
[Bone Marrow Microenvironment and Myelodysplastic Syndromes--Review].[骨髓微环境与骨髓增生异常综合征——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):290-4. doi: 10.7534/j.issn.1009-2137.2016.01.056.
3
The immunobiology of myelodysplastic neoplasms: a mini-review.骨髓增生异常肿瘤的免疫生物学：一篇小型综述。
Front Immunol. 2024 Sep 16;15:1419807. doi: 10.3389/fimmu.2024.1419807. eCollection 2024.
4
Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated.评估骨髓微环境可能会改变骨髓增生异常综合征的诊断和治疗方式。
Cytometry A. 2018 Jul;93(9):916-928. doi: 10.1002/cyto.a.23506. Epub 2018 Sep 13.
5
Biology of the bone marrow microenvironment and myelodysplastic syndromes.骨髓微环境生物学与骨髓增生异常综合征
Mol Genet Metab. 2015 Sep-Oct;116(1-2):24-8. doi: 10.1016/j.ymgme.2015.07.004. Epub 2015 Jul 20.
6
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia.鉴定骨髓增生异常综合征和急性髓系白血病中的骨髓微环境群体。
J Vis Exp. 2023 Nov 10(201). doi: 10.3791/66093.
7
Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.骨髓增生异常综合征：重新探讨骨髓微环境在疾病发病机制中的作用。
Int J Hematol. 2012 Jan;95(1):17-25. doi: 10.1007/s12185-011-1001-x. Epub 2012 Jan 6.
8
9
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.对于原发性骨髓增生异常综合征患者，骨髓纤维化具有预后价值，可用于当前的治疗方法和新的风险分层系统。
Mod Pathol. 2014 May;27(5):681-9. doi: 10.1038/modpathol.2013.187. Epub 2013 Nov 1.
10
Deep sequencing of bone marrow microenvironments of patients with del(5q) myelodysplastic syndrome reveals imprints of antigenic selection as well as generation of novel T-cell clusters as a response pattern to lenalidomide.对伴有 del(5q)骨髓增生异常综合征患者骨髓微环境进行深度测序，揭示了免疫原性选择的痕迹，以及作为来那度胺反应模式产生新的 T 细胞簇。
Haematologica. 2019 Jul;104(7):1355-1364. doi: 10.3324/haematol.2018.208223. Epub 2019 Jan 17.
本文引用的文献
1
[The Latest Research Progress on Myelodysplastic Syndrome Patient-derived Mesenchymal Stem Cell--Review].[骨髓增生异常综合征患者来源间充质干细胞的最新研究进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Aug;30(4):1286-1290. doi: 10.19746/j.cnki.issn.1009-2137.2022.04.051.
2
IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function.骨髄树突状细胞中的 IL-1β 表达受 TLR2 激动剂诱导，并调节 HSC 功能。
Blood. 2022 Oct 6;140(14):1607-1620. doi: 10.1182/blood.2022016084.
3
The Coming of Age of Preclinical Models of MDS.骨髓增生异常综合征临床前模型的时代来临
Front Oncol. 2022 Mar 16;12:815037. doi: 10.3389/fonc.2022.815037. eCollection 2022.
4
Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.异常的 DNA 甲基化影响骨髓间充质基质细胞中骨髓增生异常综合征和初发急性髓系白血病的 HOX 基因表达。
Cancer Gene Ther. 2022 Aug;29(8-9):1263-1275. doi: 10.1038/s41417-022-00441-w. Epub 2022 Feb 22.
5
Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.骨髓增生异常综合征来源的骨髓基质细胞在体内发生改变，但无克隆性突变。
Nat Commun. 2021 Oct 25;12(1):6170. doi: 10.1038/s41467-021-26424-3.
6
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling.TLR7 激动剂通过矛盾性抑制炎症信号增强 Rps14(uS11)缺陷小鼠的造血功能。
Blood Adv. 2021 Oct 26;5(20):4112-4124. doi: 10.1182/bloodadvances.2020003055.
7
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS.造血衰老、克隆性造血和骨髓增生异常综合征中的固有免疫途径与炎症
J Exp Med. 2021 Jul 5;218(7). doi: 10.1084/jem.20201544. Epub 2021 Jun 15.
8
Oncogenic Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice.非造血骨髓微环境中的致癌激活导致小鼠骨髓增生异常综合征。
Mol Cancer Res. 2021 Sep;19(9):1596-1608. doi: 10.1158/1541-7786.MCR-20-0275. Epub 2021 Jun 4.
9
Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes.异常 Toll 样受体信号在骨髓增生异常综合征发病机制中的作用。
Front Immunol. 2020 Jun 17;11:1236. doi: 10.3389/fimmu.2020.01236. eCollection 2020.
10
Myelodysplastic syndromes: moving towards personalized management.骨髓增生异常综合征：走向个体化治疗。
Haematologica. 2020 Jul;105(7):1765-1779. doi: 10.3324/haematol.2020.248955. Epub 2020 May 21.
Zotero 插件